Mapping the future of common diseases: lessons from psoriasis
Related Experiment Video
Updated: Jul 18, 2026

Measuring Psoriasis Severity at Home
Published on: March 1, 2024
Emiliano Giardina1, Cecilia Sinibaldi, Giuseppe Novelli
1Centre of Excellence for Genomic Risk Assessment in Multifactorial and Complex Diseases, School of Medicine, Tor Vergata University of Rome, Italy.
Abstract:
Psoriasis (OMIM*177900) is a common, chronic, hyperproliferative inflammatory disorder of the skin affecting approximately 2% of Caucasians. Despite the prevalence of psoriasis in general population, significant differences in the incidence among Japanese, Eskimos, West Africans, north American blacks and American natives are well known. The cause for these variations are likely to be both genetic and environmental. Independent genomewide scans have suggested the involvement of a large number of chromosomal regions (loci), but so far only poor susceptibility genes have been suggested. We discuss genetic basis of the disease, results and interpretations of relevant studies, with particular regard to study design and future perspectives. Indeed to date, mapping genes which contribute to complex diseases is one of the major challenge in the post-genomic era.
Related Concept Videos
Pharmacogenomics: Identification of New Drug Targets
EPS and iPS Cells in Disease Research
iPS Cell Differentiation
Microorganisms in Medicine and Therapeutics
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Introduction to Language of Pathophysiology ll